General Information
Revision date
2019-07-01
Product name
Cediranib, Free Base
CAS No.
288383-20-0
Icons in SDS
Company Information
company name
LC Laboratories
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302+H312+H332
Hazard statements
Code
Statements
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
Hazard statements
pharmaceutically active substance Substance Class Identifier: Tumorigen; Drug; Human Data May be harmful if inhaled, swallowed, or through skin absorption Ingestion may cause hypertension (high blood pressure), proteinurea (protein in the urine), fatigue, anorexia (loss of appetite), weight loss, diarrhea, dysphonia (hoarseness of voice)/voice changes, pyrexia (fever), dry skin, palmar-plantar erythrodysesthesia syndrome (also known as hand-foot syndrome manifested as redness, tenderness, peeling, blistering and ulceration of the palms and soles), hypothyroidism, constipation, dehydration, xerostomia (dry mouth)/difficulty swallowing, stomatitis (inflammation/ulceration of the mucous membranes lining of the mouth), nausea, vomiting, abnormal liver function tests, dizziness, arthralgia (joint pain), myalgia (muscle pain), abdominal pain, back pain, headache/head pain, cough, and dypsnea (shortness of breath) May be irritating to skin, eyes, mucous membranes, and upper respiratory tract H302+312+332 - Harmful if swallowed, in contact with skin or if inhaled
Precautionary statements
P2562 - Do not get in eyes, on skin or on clothing WARNING For Laboratory Research Use Only
